VivaGel® is an innovative antimicrobial agent being applied to a range of sexual health products by Starpharma and its partners, including:



VivaGel® (SPL7013, or astodrimer sodium) has been shown in laboratory studies to inactivate up to 99.9% of viruses, including HIV, the herpes virus (HSV), and the human papillomavirus (HPV), and has been shown in various laboratory-based disease models to inhibit infection with these viruses.  VivaGel® has also been shown to have antibacterial effects.  Several clinical studies have successfully tested the safety and efficacy of VivaGel®.


VivaGel® formulated as a mucoadhesive gel and delivered vaginally has been shown to relieve the signs and symptoms of bacterial vaginosis (BV), and to reduce risk of recurrence of BV, in clinical studies.  Further clinical studies are planned to confirm the effectiveness of VivaGel® in preventing recurrence of BV.





© Starpharma Holdings Limited 2014